Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training


      High density lipoprotein cholesterol (HDL-C) is a primary risk factor for cardiovascular disease. Apolipoprotein A-1 (apoA1) is the major HDL-associated apolipoprotein. The −75G/A single nucleotide polymorphism (SNP) in the apolipoprotein A1 gene (APOA1) promoter has been reported to be associated with HDL-C concentrations as well as HDL-C response to dietary changes in polyunsaturated fat intake. We examined the effect of this APOA1 SNP on exercise-induced changes in HDL subfraction distribution. From a cohort of healthy normolipidemic adults who volunteered for 6 months of supervised aerobic exercise, 75 subjects were genotyped for the −75G/A SNP. Of these, 53 subjects were G homozygotes (G/G) and 22 were A carriers (A/G and A/A). HDL subfractions were measured by nuclear magnetic resonance (NMR) spectroscopy by adding categories HDL-C 1 + 2 for the small subfraction, and HDL-C 3 + 4 + 5 for the large. The change in total HDL-C after exercise was 0.8 ± 7.2 mg/dL (+1.7%), and was not statistically significant. HDL subfraction amounts also did not significantly change with exercise training in the total cohort or in G homozygotes or A carriers. The amount of the large HDL subfraction increased in the G homozygotes and decreased in the A carriers (mean ± S.E.M., 1.8 ± 6.6 mg/dL versus −6.1 ± 2.3 mg/dL, p < 0.0005). In contrast, the amount of the small HDL subfraction decreased in G homozygotes and increased in A carriers (−1.3 ± 6.6 mg/dL versus 4.7 ± 1.2 mg/dL, p < 0.005). These results show that genetic variation at the APOA1 gene promoter is associated with HDL subfraction redistribution resulting from exercise training.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Barter P.
        • Kastelein J.
        • Nunn A.
        • Hobbs R.
        CN-FFEB: high density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.
        Atherosclerosis. 2003; 168: 195-211
        • Brewer Jr., H.B.
        • Santamarina-Fojo S.
        Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter.
        Am J Cardiol. 2003; 92: 10K-16K
        • Wilson P.W.
        • Abbott R.D.
        • Castelli W.P.
        High density lipoprotein cholesterol and mortality. The Framingham Heart Study.
        Arteriosclerosis. 1988; 8: 737-741
        • Freedman D.S.
        • Otvos J.D.
        • Jeyarajah E.J.
        • et al.
        Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
        Arterioscler Thromb Vasc Biol. 1998; 18: 1046-1053
        • Rosenson R.S.
        • Otvos J.D.
        • Freedman D.S.
        Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) Trial.
        Am J Cardiol. 2002; 90: 89-94
        • Decossin C.
        • Castro G.
        • Derudas B.
        • et al.
        Subclasses of LpA-I in coronary artery disease: distribution and cholesterol efflux ability.
        Eur J Clin Invest. 1997; 27: 299-307
        • Sich D.
        • Saidi Y.
        • Giral P.
        • et al.
        Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
        Metabolism. 1998; 47: 965-973
        • Asztalos B.
        • Lefevre M.
        • Wong L.
        • et al.
        Differential response to low-fat diet between low and normal HDL-cholesterol subjects.
        J Lipid Res. 2000; 41: 321-328
        • Kuller L.
        • Arnold A.
        • Tracy R.
        • et al.
        Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1175-1180
        • Ballantyne F.C.
        • Clark R.S.
        • Simpson H.S.
        • Ballantyne D.
        High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects.
        Metabolism. 1982; 31: 433-437
        • Pascot A.
        • Lemieux I.
        • Prud’homme D.
        • et al.
        Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.
        J Lipid Res. 2001; 42: 2007-2014
        • Williams P.T.
        • Krauss R.M.
        • Vranizan K.M.
        • et al.
        Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women.
        Arterioscler Thromb. 1992; 12: 332-340
        • Otvos J.D.
        Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.
        Clin Lab. 2002; 48: 171-180
        • Jeenah M.
        • Kessling A.
        • Miller N.
        • Humphries S.
        G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.
        Mol Biol Med. 1990; 7: 233-241
        • Sadaf A.
        • Siddiqui S.
        • Lestringant G.G.
        • Frossard P.M.
        Apolipoprotein AI promoter variant in blood pressure determination.
        Clin Genet. 2002; 61: 314-316
        • Lahoz C.
        • Pena R.
        • Mostaza J.M.
        • et al.
        CN-RSG: Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.
        Atherosclerosis. 2003; 168: 289-295
        • Ordovas J.M.
        • Corella D.
        • Cupples L.A.
        • et al.
        Polyunsaturated fatty acids modulate the effects of the APOA1 G–A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study.
        Am J Clin Nutr. 2002; 75: 38-46
        • Juo S.H.
        • Wyszynski D.F.
        • Beaty T.H.
        • Huang H.Y.
        • Bailey-Wilson J.E.
        Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: a meta-analysis.
        Am J Med Genet. 1999; 82: 235-241
        • Barre D.E.
        • Guerra R.
        • Verstraete R.
        • et al.
        Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels.
        J Lipid Res. 1994; 35: 1292-1296
      1. Seip RL, Otvos J, Bilbie C, et al. The effect of apolipoprotein E Genotype on serum lipoprotein particle response to exercise. Atherosclerosis (in press).

        • Thompson P.D.
        • Tsongalis G.J.
        • Seip R.L.
        • et al.
        Apolipoprotein e genotype and changes in serum lipids and maximal oxygen uptake with exercise training.
        Metabolism. 2004; 53: 193-202
        • Richard P.
        • Thomas G.
        • de Zulueta M.P.
        • et al.
        Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.
        Clin Chem. 1994; 40: 24-29
        • Otvos J.D.
        • Jeyarajah E.J.
        • Bennett D.W.
        Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy.
        Clin Chem. 1991; 37: 377-386
        • Durstine J.L.
        • Grandjean P.W.
        • Cox C.A.
        • Thompson P.D.
        Lipids, lipoproteins, and exercise.
        J Cardiopulm Rehabil. 2002; 22: 385-398
        • Kraus W.E.
        • Houmard J.A.
        • Duscha B.D.
        • et al.
        Effects of the amount and intensity of exercise on plasma lipoproteins.
        N Engl J Med. 2002; 347: 1483-1492
        • Thomas T.R.
        • Smith B.K.
        • Donahue O.M.
        • et al.
        Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractions.
        Metabolism. 2004; 53: 749-754
        • Wilund K.R.
        • Colvin P.L.
        • Phares D.
        • Goldberg A.P.
        • Hagberg J.M.
        The effect of endurance exercise training on plasma lipoprotein: AI and lipoprotein AI:AII concentrations in sedentary adults.
        Metabolism. 2002; 51: 1053-1060
        • Halle M.
        • Berg A.
        • Konig D.
        • Keul J.
        • Baumstark M.W.
        Differences in the concentration and composition of low-density lipoprotein subfraction particles between sedentary and trained hypercholesterolemic men.
        Metabolism. 1997; 46: 186-191
        • Frey I.
        • Baumstark M.W.
        • Berg A.
        Acute and delayed effects of prolonged exercise on serum lipoproteins. I. Composition and distribution of high density lipoprotein subfractions.
        Eur J Appl Physiol Occup Physiol. 1993; 66: 521-525
        • Krauss R.M.
        Triglycerides and atherogenic lipoproteins: rationale for lipid management.
        Am J Med. 1998; 105: 58S-62S
        • Gofman J.W.
        • Young W.
        • Tandy R.
        Ischemic heart disease, atherosclerosis, and longevity.
        Circulation. 1966; 34: 679-697
        • Knoblauch H.
        • Bauerfeind A.
        • Krahenbuhl C.
        • et al.
        Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population.
        Hum Mol Genet. 2002; 11: 1477-1485
        • Leon A.S.
        • Gaskill S.E.
        • Rice T.
        • et al.
        Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study.
        Int J Sports Med. 2002; 23: 1-9
        • Halverstadt A.
        • Phares D.A.
        • Ferrell R.E.
        • et al.
        High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype.
        Metabolism. 2003; 52: 1505-1511
        • Herbert P.N.
        • Bernier D.N.
        • Cullinane E.M.
        • et al.
        High-density lipoprotein metabolism in runners and sedentary men.
        JAMA. 1984; 252: 1034-1037
        • Olchawa B.
        • Kingwell A.B.
        • Hoang A.
        • et al.
        Physical fitness and reverse cholesterol transport.
        Arterioscler Thromb Vasc Biol. 2004; 24: 1087-1091
        • Jafari M.
        • Leaf D.A.
        • MacRae H.
        • et al.
        The effects of physical exercise on plasma prebeta-1 high-density lipoprotein.
        Metabolism. 2003; 52: 437-442
        • Williams P.T.
        The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels.
        Metabolism. 2004; 53: 700-709
        • Sviridov D.
        • Kingwell B.
        • Hoang A.
        • Dart A.
        • Nestel P.
        Single session exercise stimulates formation of prebeta 1-HDL in leg muscle.
        J Lipid Res. 2003; 44: 522-526
        • Seip R.L.
        • Angelopoulos T.J.
        • Semenkovich C.F.
        Exercise induces lipoprotein lipase gene expression in skeletal muscle but not fat in sedentary adults.
        Amer J Physiol Endocrinol Metab. 1995; 268: E229-E236